By Mauro Orru Roche Holding said its investigational treatment, inavolisib, showed promise in a late-stage study to treat patients with breast cancer. The Swiss pharmaceutical company said Tuesday…
Read more Roche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage StudyBy Adria Calatayud Novartis said an interim analysis from a phase 3 trial to evaluate its investigational iptacopan drug in patients with kidney disease nephropathy achieved positive results,…
Read more Novartis Says Kidney Drug Phase 3 Trial Reaches Positive Interim ResultBy David Sachs Roche said Friday that its Alecensa drug demonstrated the ability to reduce recurrence of lung cancer for patients in the early stage of the disease.…
Read more Roche Lung Cancer Drug Shows Promise in Phase 3 TrialBy Colin Kellaher Shares of BioVie Inc. rose sharply in premarket trading Tuesday after the clinical-stage biopharmaceutical company reported positive results from a pair of Phase 2 studies…
Read more BioVie Shares jump Premarket on Parkinson’s, Alzheimer’s Studies >BIVIBy Michael Susin GSK PLC said Monday that its Dreamm-3 Phase 3 study in patients with relapsed or refractory multiple myeloma didn’t meet its primary endpoint of progression-free…
Read more GSK Says Dreamm-3 Phase 3 Study For Blenrep Didn’t Meet Primary EndpointModerna stock shot up after Merck said it is exercising an option to work on a personalized cancer vaccine with the Covid-19 vaccine maker. Merck (ticker: MRK) will…
Read more Moderna Stock Takes Off on Cancer Vaccine News
